Cargando…
The Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF) trial: arrhythmia suppression, blood pressure control, and potential interactions
[Figure: see text]
Autores principales: | Steinberg, Jonathan S, Blount, Nicholas, Ponomarev, Dmitry, Shabanov, Vitaly, Pokushalov, Evgeny, Romanov, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228602/ https://www.ncbi.nlm.nih.gov/pubmed/37084084 http://dx.doi.org/10.1093/europace/euad107 |
Ejemplares similares
-
Quality of life changes: a prospective evaluation after surgery ablation atrial fibrillation
por: Chernyavskiy, Alexander, et al.
Publicado: (2015) -
Outcomes of Cryoballoon Ablation in High- and Low-Volume Atrial Fibrillation Ablation Centres: A Russian Pilot Survey
por: Mikhaylov, Evgeny N., et al.
Publicado: (2015) -
Detecting and monitoring arrhythmia recurrence following catheter ablation of atrial fibrillation
por: Ajijola, Olujimi A., et al.
Publicado: (2015) -
Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry
por: Kornej, Jelena, et al.
Publicado: (2019) -
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
por: Hohnloser, Stefan H, et al.
Publicado: (2019)